STOCK TITAN

Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences

Myriad Genetics (NASDAQ: MYGN) said its management will participate in two investor healthcare conferences in late 2025.

(Neutral)
(Neutral)
Tags
conferences

Myriad Genetics (NASDAQ: MYGN) said its management will participate in two investor healthcare conferences in late 2025. Wolfe Research Healthcare Conference — fireside chat on Nov. 18, 2025 at 1:20 pm ET. Piper Sandler Healthcare Conference — fireside chat on Dec. 2, 2025 at 12:00 pm ET. Both presentations will be available via live audio webcasts in the investor information section at investor.myriad.com.

Loading...
Loading translation...
Argus Nov 11 session
+3.09% close to close Open Argus
Details

News Market Reaction – MYGN

On Nov 11, the day this news came out, MYGN closed 3.09% above the previous close.

Data tracked by StockTitan Argus for the Nov 11 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

SALT LAKE CITY, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced Myriad management will participate in two upcoming healthcare conferences.

  • The 7th Annual Wolfe Research Healthcare Conference with a fireside chat on Tuesday, Nov. 18, 2025, at 1:20 pm ET.

  • The 37th Annual Piper Sandler Healthcare Conference with a fireside chat on Tuesday, Dec. 2, 2025, at 12:00 pm ET.

The presentations will be available through live audio webcast links in the investor information section of Myriad’s website at investor.myriad.com. 

About Myriad Genetics
Myriad Genetics is a leading molecular diagnostic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad Genetics develops and offers molecular tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where molecular insights can significantly improve patient care and lower healthcare costs. For more information, visit www.myriad.com.

Investor Contact 
Matt Scalo 
(801) 584-3532 
IR@myriad.com 

Media Contact 
Kate Schraml
(224) 875-4493
PR@myriad.com


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Myriad Genetics (MYGN) present at the Wolfe Research Healthcare Conference?

Myriad will present on Nov. 18, 2025 at 1:20 pm ET with a fireside chat.

What time is Myriad Genetics (MYGN) scheduled for the Piper Sandler Healthcare Conference?

Myriad is scheduled for a fireside chat on Dec. 2, 2025 at 12:00 pm ET.

How can investors watch Myriad Genetics (MYGN) conference presentations?

Presentations will stream via live audio webcast on the investor site at investor.myriad.com.

Are Myriad Genetics (MYGN) conference events live or pre-recorded?

The company announced the events as live fireside chats with audio webcasts.

Will Myriad Genetics (MYGN) provide slides or replay for the Nov. 18 and Dec. 2 presentations?

The announcement specifies live audio webcasts; check investor.myriad.com for any slides or replay availability.

Keep reading